COVID - 19 Vaccination Update - Day 466 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 26 APR 2022 8:18 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 188 Crore landmark milestone (188,16,99,433) today. More than 19 lakh (19,67,717) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10404894
	2^nd Dose	10013852
	Precaution Dose	4735247
FLWs	1^st Dose	18415225
	2^nd Dose	17534869
	Precaution Dose	7444136
Age Group 12-14 years	1^st Dose	27485282
	2^nd Dose	4337894
Age Group 15-18 years	1^st Dose	58254580
	2^nd Dose	41725296
Age Group 18-44 years	1^st Dose	555574630
	2^nd Dose	476515377
	Precaution Dose	112705
Age Group 45-59 years	1^st Dose	202896180
	2^nd Dose	187591998
	Precaution Dose	402585
Over 60 years	1^st Dose	126847987
	2^nd Dose	116865644
	Precaution Dose	14541052
Cumulative 1^st dose administered		999878778
Cumulative 2^nd dose administered		854584930
Precaution Dose		27235725
Total		1881699433

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 26^th April, 2022 (466^th Day)
HCWs	1^st Dose	63
	2^nd Dose	688
	Precaution Dose	17698
FLWs	1^st Dose	85
	2^nd Dose	1195
	Precaution Dose	39307
Age Group 12-14 years	1^st Dose	356432
	2^nd Dose	572246
Age Group 15-18 years	1^st Dose	47365
	2^nd Dose	147263
Age Group 18-44 years	1^st Dose	36164
	2^nd Dose	407133
	Precaution Dose	9799
Age Group 45-59 years	1^st Dose	5235
	2^nd Dose	85791
	Precaution Dose	36245
Over 60 years	1^st Dose	3567
	2^nd Dose	55278
	Precaution Dose	146163
Cumulative 1^st dose administered		448911
Cumulative 2^nd dose administered		1269594
Precaution Dose		249212
Total		1967717

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.